ATRX — Adhera Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $0.06m
- $8.45m
Annual cashflow statement for Adhera Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.8 | -12 | -3.77 | -6.35 | -2.11 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 8.29 | 2.65 | 1.78 | 5.68 | 0.496 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.48 | 0.506 | 1.4 | 0.009 | 0.203 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -9.61 | -8.74 | -0.588 | -0.665 | -1.42 |
| Capital Expenditures | -0.074 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.074 | 0 | — | — | — |
| Financing Cash Flow Items | 0 | -0.707 | -0.114 | -0.101 | -0.346 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.5 | 4.87 | 0.539 | 0.739 | 1.37 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.81 | -3.87 | -0.049 | 0.074 | -0.044 |